Harris Lucinda A
Mayo Clinic, Scottsdale, Arizona 85259, USA.
Manag Care Interface. 2005 Aug;18(8):23-30.
Constipation is a common condition, affecting 2% to 27% of North Americans. Arriving at true prevalence rates is complicated, because consensus definitions are lacking. Constipation has daily implications for those affected, and, although only one-third of affected persons seek care, it is associated with high socioeconomic costs. Traditional interventions, such as fiber and laxatives, are often recommended, but high-quality evidence of their efficacy is lacking and patient dissatisfaction is common. Improved understanding of the pathophysiology of constipation has resulted in the development and approval of a new agent for the treatment of patients with chronic idiopathic constipation.
便秘是一种常见病症,影响着2%至27%的北美人。由于缺乏共识性定义,要得出确切的患病率很复杂。便秘对患者的日常生活有影响,尽管只有三分之一的患者寻求治疗,但它会带来高昂的社会经济成本。传统干预措施,如使用纤维和泻药,虽常被推荐,但缺乏其疗效的确切证据,患者不满也很常见。对便秘病理生理学的深入了解促使研发并批准了一种治疗慢性特发性便秘患者的新药。